SCHEMBL8285205

SCHEMBL8285205

Cc1cc(C(=O)c2ccc(Cl)cc2)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.44
PDE11A Q9HCR9 1/20 0.44
GAA P10253 4/20 0.39
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 3/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ABL1 P00519 1/20 0.38
KDR P35968 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 3/20 0.38
LMNA P02545 3/20 0.38
ALDH1A1 P00352 2/20 0.38
GFER P55789 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285169 0.93 PDE11A (0.45) MAPTPDE11AGAAHPGDSMN1; SMN2
SCHEMBL8285193 0.90 PDE11A (0.44) MAPTPDE11AGAASMN1; SMN2HTT
SCHEMBL8287388 0.89 MAPT (0.48) MAPTPDE11AGAAHPGDSMN1; SMN2
SCHEMBL8287393 0.86 PDE11A (0.46) MAPTPDE11AHPGDSMN1; SMN2HTT
SCHEMBL5872175 0.86 PDE11A (0.47) MAPTPDE11AGAAHPGDSMN1; SMN2
SCHEMBL8285220 0.85 PDE11A (0.43) MAPTPDE11ASMN1; SMN2MEN1KMT2A
SCHEMBL5871541 0.85 PDE11A (0.46) MAPTPDE11AGAAHPGDSMN1; SMN2
SCHEMBL8287516 0.85 RIPK1 (0.50) MAPTPDE11AGAAHPGDSMN1; SMN2
SCHEMBL8287397 0.84 PDE11A (0.46) MAPTPDE11AGAAHPGDSMN1; SMN2
SCHEMBL8287116 0.84 PDE11A (0.48) MAPTPDE11AGAAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed